SCARPELLI, Marina
 Distribuzione geografica
Continente #
NA - Nord America 21.957
EU - Europa 10.324
AS - Asia 9.292
SA - Sud America 2.212
AF - Africa 514
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 6
Totale 44.324
Nazione #
US - Stati Uniti d'America 21.597
SG - Singapore 3.140
RU - Federazione Russa 2.429
VN - Vietnam 1.837
BR - Brasile 1.752
UA - Ucraina 1.573
CN - Cina 1.249
IT - Italia 1.197
IE - Irlanda 999
HK - Hong Kong 927
DE - Germania 906
SE - Svezia 870
TR - Turchia 813
FR - Francia 610
DK - Danimarca 576
FI - Finlandia 409
GB - Regno Unito 391
KR - Corea 326
IN - India 248
CI - Costa d'Avorio 229
CA - Canada 176
BD - Bangladesh 163
AR - Argentina 156
MX - Messico 128
NL - Olanda 88
EC - Ecuador 84
ID - Indonesia 81
ZA - Sudafrica 80
IQ - Iraq 78
MA - Marocco 68
CO - Colombia 64
JP - Giappone 62
PL - Polonia 58
PK - Pakistan 51
VE - Venezuela 48
ES - Italia 45
UZ - Uzbekistan 42
PH - Filippine 39
BE - Belgio 37
CL - Cile 29
SA - Arabia Saudita 29
TN - Tunisia 28
PY - Paraguay 27
EG - Egitto 24
DZ - Algeria 22
AE - Emirati Arabi Uniti 20
AT - Austria 20
MY - Malesia 20
PE - Perù 20
TH - Thailandia 20
EE - Estonia 18
JO - Giordania 18
RO - Romania 18
EU - Europa 17
KE - Kenya 16
BO - Bolivia 15
KZ - Kazakistan 15
UY - Uruguay 14
ET - Etiopia 13
TW - Taiwan 13
AZ - Azerbaigian 11
BH - Bahrain 11
CZ - Repubblica Ceca 11
NP - Nepal 11
CR - Costa Rica 10
OM - Oman 10
IL - Israele 9
LB - Libano 9
BG - Bulgaria 8
AL - Albania 7
AO - Angola 7
GR - Grecia 7
HN - Honduras 7
KG - Kirghizistan 7
LT - Lituania 7
AU - Australia 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
NG - Nigeria 5
PT - Portogallo 5
AM - Armenia 4
BY - Bielorussia 4
IR - Iran 4
PA - Panama 4
PS - Palestinian Territory 4
SN - Senegal 4
BB - Barbados 3
GE - Georgia 3
JM - Giamaica 3
MD - Moldavia 3
ML - Mali 3
MU - Mauritius 3
NI - Nicaragua 3
PR - Porto Rico 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
Totale 44.272
Città #
Ashburn 3.359
Singapore 2.030
Chandler 1.751
Jacksonville 1.637
Fairfield 1.437
Des Moines 1.204
Dallas 1.134
Dublin 997
Boardman 906
Hong Kong 891
Wilmington 816
San Jose 799
Woodbridge 642
Ho Chi Minh City 605
Seattle 583
Houston 574
New York 559
Cambridge 426
The Dalles 415
Hanoi 408
Lawrence 402
Princeton 402
San Mateo 390
Lauterbourg 360
Beijing 309
Milan 294
Ann Arbor 290
Moscow 266
Los Angeles 244
Abidjan 229
Centro 213
San Diego 179
Hefei 178
São Paulo 152
Munich 116
London 99
Haiphong 95
Da Nang 92
Chicago 90
Santa Clara 79
Pune 78
Helsinki 74
Orem 74
Buffalo 72
Council Bluffs 67
Washington 63
Mexico City 62
Miano 61
Shanghai 58
Turku 53
Tokyo 52
Rio de Janeiro 50
Warsaw 48
Redmond 47
Montreal 46
Vancouver 46
Columbus 45
Frankfurt am Main 45
Guangzhou 45
Norwalk 44
Turin 42
Tashkent 40
Atlanta 39
Brooklyn 39
Izmir 39
Wuhan 39
Baghdad 38
Curitiba 38
Johannesburg 37
Salt Lake City 36
Brussels 34
Guayaquil 34
Phoenix 34
Amsterdam 33
Chennai 33
Denver 33
Manchester 33
Porto Alegre 31
Ancona 29
Falls Church 29
Elk Grove Village 28
Belo Horizonte 27
San Francisco 27
Biên Hòa 26
Hải Dương 26
Rome 26
Brasília 25
Stockholm 25
Can Tho 24
Dhaka 24
Jiaxing 23
Thái Nguyên 23
Campinas 22
Poplar 21
Quito 21
New Delhi 20
Quận Ba 20
Thái Bình 20
Istanbul 19
Marche 19
Totale 27.958
Nome #
Role of electron microscopy in the diagnosis of CADASIL syndrome: a study of 32 patients 762
Metabolic phenotype of bladder cancer 260
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 219
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 217
Immunotherapy in genitourinary cancers: Where are we going? 208
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 203
Are liver nested stromal epithelial tumors always low aggressive? 201
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 198
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 194
2004 WHO classification of the renal tumors of the adults. 191
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 191
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 191
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 189
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 185
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 184
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 181
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 178
A rare case of chordoma and craniopharyngioma treated by an endoscopic endonasal, transtubercular transclival approach. 175
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 174
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 173
Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807 172
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 170
Standardized mitotic counts in breast cancer evaluation of the method 168
Secondary neoplasms of the urinary system and male genital organs. 167
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 166
HER family receptor expression and prognosis in pancreatic cancer 165
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 165
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 164
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 163
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 161
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 161
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 160
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 160
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 159
Endoscopy-verified occult subependymal dissemination of glioblastoma and brain metastasis undetected by MRI: prognostic significance. 158
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 157
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 156
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 156
Microbiome and cancers, with focus on genitourinary tumors 155
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 154
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 153
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 152
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 152
Active surveillance for low-risk prostate cancer. 151
Metabolic Alterations in Renal and Prostate Cancer 151
Seminoma Retroperitoneal Relapse 23 Years After Surgery 151
Meningioma-like cerebral relapse of Hodgkin's disease. 147
Bone targeting agents in patients with metastatic prostate cancer: State of the art 147
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 146
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 145
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 145
Subarachnoid haemorrhage due to widely metastatising malignant ependymoma. 145
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 145
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 145
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions 144
Is There a Role for Immunotherapy in Prostate Cancer? 143
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 143
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 142
2009 update on the classification of renal epithelial tumors in adults 141
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 141
Angioblastic parasellar extradural tumours. 140
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 140
[Magnetic resonance in the pathologic evaluation of the isolated human brain]. 140
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 139
Genitourinary cancers: molecular determinants for personalized therapies 139
Rare synchronous association of vestibular schwannoma and indolent insular oligodendroglioma in a patient without neurofibromatosis: controversial issue of timing for surgical treatment of asymptomatic low-grade gliomas. 139
Epileptogenic Low-Grade Tumours in Childhood: Outcome after Lesionectomy 138
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 138
Seminal Vesicle Intraepithelial Neoplasia Versus Basal Cell Hyperplasia in a Seminal Vesicle. 137
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. 137
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 137
A low grade PIN-like neoplasm of the transition zone immunohistochemically negative for basal cell markers: a possible example of low grade adenocarcinoma with stratified epithelium. 136
A contemporary update on pathology reporting for urinary bladder cancer. 136
Pd-l1 inhibitors for the treatment of prostate cancer 136
Prostatic Intraepithelial Neoplasia (pin) - Performance of Bayesian Belief Network For Diagnosis and Grading. 135
Mitochondrial encephalomyopathy lactic acidosis and strokelike episodes mimicking occipital idiopathic epilepsy. 134
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 134
Bladder cancer: molecular determinants of personalized therapy 133
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 132
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 132
An overview of emerging immunotargets of genitourinary tumors 132
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 132
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers 132
Morphological diagnosis of urothelial neoplasms. 131
SURGICAL TREATMENT FOR GLIOBLASTOMA MULTIFORME: OUTCOME AND ANALYSIS OF PROGNOSTIC FACTORS ESPECIALLY ORIENTED TO THE EXTENT OF SURGICAL RESECTION 131
Present and future of personalized medicine in adult genitourinary tumors 131
Epigenetic modifications and modulators in prostate cancer 131
"No pay, no play" or from "defensive or passive pathology" to "active, clinically oriented pathology" 130
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 130
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 130
Computer assisted discrimination of glioblastomas 130
Occurrence of Cell-death (apoptosis) In Prostatic Intraepithelial Neoplasia 129
[Intracranial pressure in traumatic brain laceration and intracerebral hematomas (author's transl)]. 128
The identification of immunological biomarkers in kidney cancers 128
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. 128
Quantitative-analysis of Prostatic Intraepithelial Neoplasia On Tissue-sections. 127
From undergraduate medical school student to visible pathologist 127
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 127
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 127
Cardiac myxoma with glandular elements metastatic to the brain 12 years after the removal of the original tumor 126
Totale 15.959
Categoria #
all - tutte 213.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 0 0 0 0 0 0 232
2021/20223.031 317 620 95 136 28 269 82 202 192 273 190 627
2022/20235.798 523 459 326 462 379 1.580 3 350 1.303 34 267 112
2023/20243.068 555 78 200 429 510 696 53 75 6 53 26 387
2024/20256.021 657 522 240 141 214 222 560 262 1.535 462 505 701
2025/202615.834 787 1.103 1.098 1.586 1.508 1.030 2.752 1.669 2.067 1.256 285 693
Totale 44.736